<!DOCTYPE html>
<html lang="en"
>
<head>
    <title>Infinite regress</title>
    <!-- Using the latest rendering mode for IE -->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">



<link rel="canonical" href="http://miljko.org">
        <meta name="author" content="Miloš Miljković" />

    <!-- Enable latex plugin -->


    <!-- Open Graph tags -->
        <meta property="og:site_name" content="Infinite regress" />
        <meta property="og:type" content="website"/>
        <meta property="og:title" content="Infinite regress"/>
        <meta property="og:url" content="http://miljko.org"/>
        <meta property="og:description" content="Infinite regress"/>

    <meta name="twitter:card" content="summary">
        <meta name="twitter:site" content="@miljko">
        <meta name="twitter:creator" content="@miljko">
    <meta name="twitter:domain" content="http://miljko.org">

    <!-- Bootstrap -->
        <link rel="stylesheet" href="http://miljko.org/theme/css/bootstrap.aplan.min.css" type="text/css"/>
    <link href="http://miljko.org/theme/css/font-awesome.min.css" rel="stylesheet">

    <link href="http://miljko.org/theme/css/pygments/native.css" rel="stylesheet">
        <link href="http://miljko.org/theme/css/typogrify.css" rel="stylesheet">
    <link rel="stylesheet" href="http://miljko.org/theme/css/style.css" type="text/css"/>

        <link href="http://miljko.org/rss/index.xml" type="application/rss+xml" rel="alternate"
              title="Infinite regress RSS Feed"/>


    <style type="text/css">
    p {
        margin-top: 18px;
        margin-bottom: 18px;
    }
    </style>

</head>
<body>

<div class="navbar navbar-default navbar-fixed-top" role="navigation">
    <div class="container">
        <div class="navbar-header">
            <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-ex1-collapse">
                <span class="sr-only">Toggle navigation</span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
            </button>
            <a href="http://miljko.org/" class="navbar-brand">
Infinite regress            </a>
        </div>
        <div class="collapse navbar-collapse navbar-ex1-collapse">
            <ul class="nav navbar-nav">
                        <li >
                            <a href="http://miljko.org/category/blog.html">Blog</a>
                        </li>
                        <li >
                            <a href="http://miljko.org/category/pisanije.html">Pisanije</a>
                        </li>
                        <li >
                            <a href="http://miljko.org/category/reviews.html">Reviews</a>
                        </li>
            </ul>
            <ul class="nav navbar-nav navbar-right">
                <li><a href="http://miljko.org/archives.html"><i class="fa fa-th-list"></i><span class="icon-label">Archives</span></a></li>
            </ul>
        </div>
        <!-- /.navbar-collapse -->
    </div>
</div> <!-- /.navbar -->

<div class="container">
    <div class="row">
        <div class="col-lg-12">

            <article>
                <h2><a href="http://miljko.org/eng/2014/11/05/myeloid-sarcoma-a-slide-show/">Myeloid sarcoma, a slide&nbsp;show</a></h2>
                <div class="summary"><p>This tumor board was almost two month ago. The case is fascinating, but the presentation had too much patient-related information for me to be comfortable posting it here. I ended up removing most of the interesting slides, though it remains a decent introduction to <span class="caps">GATA2</span> mutations/MonoMAC syndrome, and a nice overview of chloroma/granulomatous/myeloid&nbsp;sacroma.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/11/05/myeloid-sarcoma-a-slide-show/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/11/03/on-medical-euphemisms/">On medical&nbsp;euphemisms</a></h2>
                <div class="summary"><p>Observe George Carlin discussing how euphemisms are invading the English&nbsp;language:</p>
<iframe width="420" height="315" src="//www.youtube.com/embed/vuEQixrBKCc"
frameborder="0" allowfullscreen></iframe>

<p>I first heard a version of this years ago, back in Serbia, while I was still
a med student. It hadn&#8217;t left much of an impression, but I can imagine myself
nodding my head and thinking <em>ha ha, yes, stupid Americans, ruining their own
language</em>, or something comparably&nbsp;obnoxious.</p>
<p>Well, I&#8217;ve, erm, matured since then. True, some euphemisms now inspire
rage instead of vague amusement, like my two&nbsp;favorites:</p>
<ul>
<li>
<p><span class="dquo">&#8220;</span>I just wanted to let you know&#8221; instead of &#8220;I&#8217;m telling you&#8221;, and its
  relatives &#8220;Please let me know&#8221;, and &#8220;Thank you for letting me know&#8221;.
  Physicians are particularly fond of this, for we are the gatekeepers of
  knowledge, and the only reason you know something is because we are letting
  you. Don&#8217;t worry though, it&#8217;s not just you, we say that to each other all the&nbsp;time.</p>
</li>
<li>
<p><span class="dquo">&#8220;</span>I don&#8217;t feel comfortable doing xyz&#8221; instead of &#8220;I don&#8217;t want to do
  xyz&#8221;, <a href="http://miljko.org/eng/2013/12/25/ten-common-residency-idioms-and-phrases">as mentioned here</a>.</p>
</li>
</ul>
<p>Most of them, though—particularly ones we use with patients—have a good
reason to exist. <a href="http://www.radiolab.org/story/translation/">The Radiolab segment which inspired this post</a>
made fun of &#8220;making someone comfortable&#8221; being used for dying <span class="caps">ICU</span> patients.
Instead of… what, exactly? Euthanasia? There is a difference between giving
someone drugs usualy meant for comfort—opioids, primarily—in order to kill them,
and giving them opioids for pain and comfort knowing it may shorten their&nbsp;life.</p>
<p>Then there are turns of phrase used <em>because</em> they are euphemisms. &#8220;You
should get your affairs in order&#8221;, &#8220;your time is becoming limited&#8221;, &#8220;at
this point we should concentrate on quality of life, not quantity&#8221; are
all ways of saying &#8220;I don&#8217;t know when you&#8217;ll die, but it will be soon,
so start planning the funeral&#8221;. I am sure Mr. Carlin would appreciate
getting it straight, but not every patient is as stoic. We can easily
be more blunt if asked to do so, but you cannot un-hit a patient with a
sledgehammer like that. So the default is to err on the side of&nbsp;softness.</p>
<p>Then again, most of the euphemisms we use with patients also make <em>us</em>
more comfortable with the sitation. What I wrote above may then just be
my rationalizing it away with a convenient it&#8217;s-best-for-the-patient
mantra. In truth—to use another common phrase—euphemisitis is a
<em>multifactorial</em> condition (as in, I have no idea what the reasons are,
but it&#8217;s probably a little bit of&nbsp;everything).</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/11/03/on-medical-euphemisms/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/11/01/t-cellhistiocyte-rich-large-b-cell-lymphoma/">T-cell/histiocyte-rich large B-cell&nbsp;lymphoma</a></h2>
                <div class="summary"><p>Another month, another tumor board talk. The slides aren&#8217;t self-sufficient, I&#8217;m afraid, but the references might be a good starting point for learning more about <span class="caps">TCHRLBCL</span>[^wtf], or diffuse large B-cell lymphoma in general. I&#8217;d start with [this excellent review article on <span class="caps">DLBCL</span> treatment][ccr], written by several <span class="caps">NCI</span>&nbsp;attendings[^attnd].</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/11/01/t-cellhistiocyte-rich-large-b-cell-lymphoma/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/10/18/eol-history-a-slide-show/">History of advance care planning in the <span class="caps">US</span></a></h2>
                <div class="summary"><p>Here is a slide show I had to make during my [pain and palliative rotation][ppc], which ended up being an updated rehash of [a review article I wrote for Cancer Journal on the history of end-of-life care][eolreview]. The article itself is behind a paywall, but you can find the <span class="caps">PDF</span> on&nbsp;[ResearchGate][rgate].</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/10/18/eol-history-a-slide-show/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/10/11/stem-cell-transplants-a-slide-show/">Stem cell transplants, a slide&nbsp;show</a></h2>
                <div class="summary"><p>As first-year fellows, we have to present a case at the Medical Oncology Service tumor board every four weeks. Obviously, I can&#8217;t share the details of those talks here. But I <em>can</em> post a sanitized version of my slides, with all identifying information&nbsp;removed.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/10/11/stem-cell-transplants-a-slide-show/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/10/10/pain-and-palliation/">Pain. And&nbsp;Palliation.</a></h2>
                <div class="summary"><p>I am not spiritual, or religious. Living in an atheist country that
suddenly takes a turn towards militant Christian fundamentalism does
that to you. I don&#8217;t believe in woo. I do believe that American doctors
are overtreating their patients&#8217; pain, and that American patients are
too sensitized to it. Yes, the understaffed orthopedic <span class="caps">VA</span> surgery wards
where post-op patients were screaming for their morphine may have led
to the Kabuki of a nurse coming in every couple of hours to ask you
about where your pain is, and what is the <span class="caps">QUALITY</span> of the pain, and
howbadisitfromonetoten? But a cancer center is no <span class="caps">VA</span>. The ritual only
reminds those with chronic cancer pain that yes, it is still there,
and yes, it hurts more than it did 3 hours ago, and now they can&#8217;t
finish reading their book because there is a twinge every couple of
minutes while they are thinking about&nbsp;it.</p>
<p>Which is all a longwinded way of saying that I should not have enjoyed the pain
and pallitavie rotation that much. There is spirituality, there is woo, there is
a lot of pain. And yet I&nbsp;did.</p>
<p>These people know what they are doing. They have plenty of resources
available to do it. And yes, they may &#8220;do Reiki&#8221;—nothing more
than elaborate Kabuki for patients with advanced diseases—but there are
times when that is exactly what the patients need. When 4am vital
signs and checking for hepatomegaly every day just aren&#8217;t&nbsp;enough.</p>
<p>Some useful questions to ask your patients with any serious chronic
disease, if and when you have some extra time in&nbsp;clinic:</p>
<ul>
<li>Are you the same person now as you were before the diagnosis? How did you&nbsp;change?</li>
<li>What do you fear the&nbsp;most?</li>
<li>What do you hope&nbsp;for?</li>
<li>Who(m) do you rely on for support?<sup id="fnref:whom"><a class="footnote-ref" href="#fn:whom" rel="footnote">1</a></sup></li>
</ul>
<p>The patients&#8217; answers may surprise&nbsp;you.</p>
<div class="footnote">
<hr>
<ol>
<li id="fn:whom">
<p><span class="dquo">&#8220;</span>Whom&#8221; is gramaticaly correct, but interrpreted as pretentious
by most patients. Use it judiciously. Yes, I realize that what I have
written here is just as bad.&#160;<a class="footnote-backref" href="#fnref:whom" rev="footnote" title="Jump back to footnote 1 in the text">&#8617;</a></p>
</li>
</ol>
</div>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/10/10/pain-and-palliation/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/srb/2014/10/05/peti-oktobar-2014/">Peti oktobar,&nbsp;2014</a></h2>
                <div class="summary"><p><a href="http://miljko.org/srb/2013/10/05/peti-oktobar-2013/">Ovo još uvek važi</a>, uz par
nebitnih izmena i&nbsp;dopuna.</p>
<p><a href="http://www.rasakarapandza.com/random/?p=151">Ovo je još uvek najbolji tekst o petom oktobru koji ćete&nbsp;pročitati.</a></p>
<p>Iz daljine, ne čini mi se da je pravac kojim Srbija ide—ako ga ima—dobar. Isto
mislim i o Americi, ali ona je tanker koji se približava  ledenom bregu. Srbija
je izbušeni splav koji se već&nbsp;prevrnuo.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/srb/2014/10/05/peti-oktobar-2014/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/srb/2014/10/03/posle-usmle-a-pozivi/">Posle <span class="caps">USMLE</span>-a:&nbsp;pozivi</a></h2>
                <div class="summary"><p>Programi su pre nešto više od dve nedelje počeli da skidaju prijave sa <span class="caps">ERAS</span>-a.
Ako vas je neko već pozvao, čestitam! Ako nije<sup id="fnref:prijava"><a class="footnote-ref" href="#fn:prijava" rel="footnote">1</a></sup>, još nije vreme za
brigu—većina programa pozivnice šalje u talasima, svake dve-tri nedelje, sve do
kraja oktobra-sredine&nbsp;novembra.</p>
<p>Ako vam ni do tada ne stigne ništa, evo šta sigurno ne treba raditi—spemovati
jadne direktore i njihove koordinatore generičkim molbama za intervju.
U najboljem slučaju će ignorisati vaš mejl, u najgorem će vas skinuti sa spiska
potencijalnih kandidata jer ne umete da pratite molbu sa sajta da ih ne
kontaktirate za takve&nbsp;stvari.</p>
<p>Šta onda? Dve stvari: ako znate nekoga ko može garantovati za
vas, zamolite ih da proslede vaše podatke koordinatoru ili direktoru koje
poznaju<sup id="fnref:upozorenje"><a class="footnote-ref" href="#fn:upozorenje" rel="footnote">2</a></sup>; i ako ste
već u Americi, pošaljite mejl okolnim programima da ste dostupni u kratkom roku,
za slučaj da neki kandidat otkaže razgovor dan-dva pre. Za tako nešto je dobro biti
u mestima sa visokom koncentracijom programa koji primaju strance (čitaj: Istočna obala, Čikago).
Naravno, prijavite se na te programa preko <span class="caps">ERAS</span>-a <em>pre</em> slanja&nbsp;mejla.</p>
<p>Ako ste završili sve stepove ali još niste dobili <span class="caps">ECFMG</span> sertifikat,
slobodno se prijavite—programi to obično gledaju tek kad dođe vreme za
rangiranje. Ako već morate da se prijavite bez svih stepova, Step 2 <span class="caps">CK</span>
je najmanje bitan. <span class="caps">CS</span> je i dalje najlakši za prolaz, ali je njegovo
padanje najveća crvena zastava koju nečija aplikacija može imati, tako da se
stranci bez položenog <span class="caps">CS</span>-a obično ne&nbsp;pozivaju.</p>
<p>Sledeća bitna stavka su pisma preporuke. Nema svrhe plaćati prijavu za
program koji na sajtu traži četiri pisma, a vi to četvrto još čekate.
Srećom, većina je <span class="caps">OK</span> i sa tri, dok se poslednje može dodati naknadno.
<span class="caps">MSPE</span> (&#8220;dekanovo pismo&#8221;) i transkript su neophodni, ali za strane
kandidate nebitni pošto sistemi ocenjivanja nisu uporedivi. Na žalost,
to je još jedna stavka za koju morati čekati na šalterima, hodnicima
fakulteta,&nbsp;itd.</p>
<p>Srećno!</p>
<div class="footnote">
<hr>
<ol>
<li id="fn:prijava">
<p>Ili ako još niste poslali prijavu, u kom slučaju, šta kog
đavola čekate‽&#160;<a class="footnote-backref" href="#fnref:prijava" rev="footnote" title="Jump back to footnote 1 in the text">&#8617;</a></p>
</li>
<li id="fn:upozorenje">
<p>Upozorenje: morate biti sigurni da su u
dobrim odnosima. Postoje ljudi čija bi preporuka bila garancija za brisanje sa
liste.&#160;<a class="footnote-backref" href="#fnref:upozorenje" rev="footnote" title="Jump back to footnote 2 in the text">&#8617;</a></p>
</li>
</ol>
</div>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/srb/2014/10/03/posle-usmle-a-pozivi/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/09/21/its-well-known-that-most-common-knowledge-is-false/">It’s well-known that most common knowledge is&nbsp;false</a></h2>
                <div class="summary"><p>Did you hear the one about not prescribing angiotensin receptor blockers to
patients with <span class="caps">ACE</span> inhibitor-induced angioedema? I&#8217;ve had heated debates
with residents in my old clinic who did not want to even consider ARBs for
a patient with worsening diabetic nephropathy who&#8217;s had lip swelling
while on an <span class="caps">ACE</span>-I <em>ten years ago</em>.</p>
<p>Or the one about not giving these patients amlodipine, since there
are two—<a href="http://www.ncbi.nlm.nih.gov/pubmed/19299323">yes</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/21330681">two</a>—case reports on amlodipine-associated
angioedema? Should we also stop giving them <a href="http://www.ncbi.nlm.nih.gov/pubmed/15120149">water</a>?</p>
<p>Then there are shellfish allergies and iodine contrast, fever and
atelectasis, morbid obesity and hypothyroidism… No matter how many
studies show these associations to be too weak to be clinicaly
significant, or just plain false, there will always be an attending
somewhere giving them as his or her pearl of the&nbsp;day.</p>
<p>We need some <a href="http://www.bmj.com/content/335/7633/1288">medical mythbusting</a> for physicians, not just the lay&nbsp;public.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/09/21/its-well-known-that-most-common-knowledge-is-false/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2014/09/21/how-to-spend-a-monday-morning-train-ride/">How to spend a Monday morning train&nbsp;ride</a></h2>
                <div class="summary"><ul>
<li><a href="http://calnewport.com/blog/2014/08/08/deep-habits-plan-your-week-in-advance/">Deep Habits: Plan Your Week in&nbsp;Advance</a></li>
<li><a href="http://calnewport.com/blog/2014/09/09/deep-habits-when-the-going-gets-tough-build-a-temporary-plan/">Deep Habits: When the Going Gets Tough, Build a Temporary&nbsp;Plan</a></li>
</ul>
<p>The <a href="http://zenhabits.net/weekly-review-key-to-gtd-and-achieving/"><span class="caps">GTD</span> weekly review</a> does a good of job keeping my task list
managable, but not all tasks and projects are equal. It&#8217;s good to have
a sense of when you might have time for deep thinking versus mindless
task processing&#8212;-something <span class="caps">GTD</span> doesn&#8217;t trully account for. I had been doing a
variant of weekly planning since high school, until internship destroyed
any hope of having a <em>daily</em>, let alone weekly plan. It&#8217;s time to start&nbsp;again.</p>
<p>And if you are not following <a href="http://calnewport.com/blog/">Cal Newport&#8217;s blog</a> already, you should. The man is
a&nbsp;machine.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2014/09/21/how-to-spend-a-monday-morning-train-ride/">more ...</a>
                </div>
            </article>
            <hr/>

        <ul class="pagination">
                <li class="prev"><a href="http://miljko.org/index9.html">&laquo;</a>
                </li>
                    <li class=""><a
                            href="http://miljko.org/index.html">1</a></li>
                    <li class=""><a
                            href="http://miljko.org/index2.html">2</a></li>
                    <li class=""><a
                            href="http://miljko.org/index3.html">3</a></li>
                    <li class=""><a
                            href="http://miljko.org/index4.html">4</a></li>
                    <li class=""><a
                            href="http://miljko.org/index5.html">5</a></li>
                    <li class=""><a
                            href="http://miljko.org/index6.html">6</a></li>
                    <li class=""><a
                            href="http://miljko.org/index7.html">7</a></li>
                    <li class=""><a
                            href="http://miljko.org/index8.html">8</a></li>
                    <li class=""><a
                            href="http://miljko.org/index9.html">9</a></li>
                    <li class="active"><a
                            href="http://miljko.org/index10.html">10</a></li>
                    <li class=""><a
                            href="http://miljko.org/index11.html">11</a></li>
                    <li class=""><a
                            href="http://miljko.org/index12.html">12</a></li>
                    <li class=""><a
                            href="http://miljko.org/index13.html">13</a></li>
                    <li class=""><a
                            href="http://miljko.org/index14.html">14</a></li>
                    <li class=""><a
                            href="http://miljko.org/index15.html">15</a></li>
                    <li class=""><a
                            href="http://miljko.org/index16.html">16</a></li>
                <li class="next"><a
                        href="http://miljko.org/index11.html">&raquo;</a></li>
        </ul>
        </div>
    </div>
</div>
<footer>
   <div class="container">
      <hr>
       <div class="row">
        <div class="col-xs-12" id="aboutme">
<p>
    <strong>About Miloš Miljković</strong><br/>
    <p>Hematologist/medical oncologist caring for patients with T-cell malignancies and relapsed solid tumors at the <a href="http://cancer.gov">National Cancer Institute</a> in Bethesda, Maryland.<p><a href="https://twitter.com/miljko">@miljko</a> on Twitter.
</p>        </div>
       </div>
      <hr>
      <div class="row">
         <div class="col-xs-10">&copy; 2018 Miloš Miljković
            &middot; Powered by <a href="http://docs.getpelican.com/" target="_blank">Pelican</a>,
            <a href="http://getbootstrap.com" target="_blank">Bootstrap</a>         </div>
         <div class="col-xs-2"><p class="pull-right"><i class="fa fa-arrow-up"></i> <a href="#">Top</a></p></div>
      </div>
   </div>
</footer>
<script src="http://miljko.org/theme/js/jquery.min.js"></script>

<!-- Include all compiled plugins (below), or include individual files as needed -->
<script src="http://miljko.org/theme/js/bootstrap.min.js"></script>

<!-- Enable responsive features in IE8 with Respond.js (https://github.com/scottjehl/Respond) -->
<script src="http://miljko.org/theme/js/respond.min.js"></script>

</body>
</html>